- A Nationwide Survey on the Hospital Vaccination Policies in Korea
-
Park SH, Lee MS, Kim SR, Kwak YG
- KMID: 2471905
- J Korean Med Sci.
- 2020 Mar;35(12):e76.
- doi: 10.3346/jkms.2020.35.e76
BACKGROUND: Healthcare personnel (HCP) are at risk of being exposed to or transmitting infections in hospitals, and vaccination against vaccine-preventable diseases (VPDs) is a well-known preventive strategy. Vaccination against influenza,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of a Gluten Free Diet on Hepatitis B Surface Antibody Concentration in Previously Immunized Pediatric Celiac Patients
-
Zifman E, Zevit N, Heshin-Bekenstein M, Turner D, Shamir R, Silbermintz A
- KMID: 2471622
- Pediatr Gastroenterol Hepatol Nutr.
- 2020 Mar;23(2):132-136.
- doi: 10.5223/pghn.2020.23.2.132
PURPOSE: To evaluate the effect of gluten-free diet (GFD) on hepatitis B surface antibody (HBsAb) concentrations among previously immunized pediatric celiac disease (CD) subjects. METHODS: We retrospectively evaluated pediatric CD subjects... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B Prophylaxis after Liver Transplantation in Korea: Analysis of the KOTRY Database
-
Park GC, Hwang S, Kim MS, Jung DH, Song GW, Lee KW, Kim JM, Lee JG, Ryu JH, Choi DL, Wang HJ, Kim BW, Kim DS, Nah YW, You YK, Kang KJ, Yu HC, Park YH, Lee KJ, Kim YK
- KMID: 2469941
- J Korean Med Sci.
- 2020 Feb;35(6):e36.
- doi: 10.3346/jkms.2020.35.e36
BACKGROUND: Prophylaxis for hepatitis B virus (HBV) recurrence is essential after liver transplantation (LT) in HBV-associated recipients. We conducted real-world analysis of HBV prophylaxis after LT in the Korean population. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B vaccination and immunotherapies: an update
-
Stasi C, Silvestri , Voller F
- KMID: 2470832
- Clin Exp Vaccine Res.
- 2020 Jan;9(1):1-7.
- doi: 10.7774/cevr.2020.9.1.1
World Health Organization (WHO) estimates that 257 million people were living with chronic hepatitis B virus (HBV) infection. Highest HBV prevalence was found in the WHO Western Pacific Region (6.2%)... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of Decreasing Rate of HIV and HBV Co-infection in a Nationwide Korean HIV/AIDS Cohort
-
Kim Y, Kim SW, Kwon KT, Chang HH, Jun Y, Sohn JW, Park DW, Song JY, Choi JY, Kim HY, Kim JM, Choi BY, Choi Y, Kee MK, Yoo MS, Lee JG
- KMID: 2468015
- J Korean Med Sci.
- 2020 Jan;35(3):e7.
- doi: 10.3346/jkms.2020.35.e7
From December 2006 to December 2016, 1093 human immunodeficiency virus (HIV) individuals < 70 years enrolled in Korea human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) cohort were analyzed to investigate... -
- CITED
-
- Close
- SHARE
-
- Close
- Kidney disease in patients with chronic liver disease
-
Chang JH
- KMID: 2467981
- J Korean Med Assoc.
- 2020 Jan;63(1):14-19.
- doi: 10.5124/jkma.2020.63.1.14
The kidneys are closely connected with several organs, including the liver, and can therefore be negatively affected when the liver is damaged. The most common cause of chronic liver disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Performance of Serum Asialo-α1-acid Glycoprotein for Advanced Liver Fibrosis or Cirrhosis in Patients with Chronic Hepatitis B or Nonalcoholic Fatty Liver Disease
-
Kim SU, Jeon MY, Lim TS
- KMID: 2469909
- Korean J Gastroenterol.
- 2019 Dec;74(6):341-348.
- doi: 10.4166/kjg.2019.74.6.341
BACKGROUND/AIMS: The utility of asialo-α1-acid glycoprotein (AsAGP) for assessing the fibrotic burden is unknown. This study examined the diagnostic performance of the AsAGP level for advanced liver fibrosis or cirrhosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
-
Shin H, Jung YW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim YY, Choi JY, Kim SU
- KMID: 2467249
- Clin Mol Hepatol.
- 2019 Dec;25(4):390-399.
- doi: 10.3350/cmh.2018.0103
BACKGROUND/AIMS: A risk prediction model for the development of hepatocellular carcinoma (HCC) from indeterminate nodules detected on computed tomography (CT) (Rad(CT) score) in patients with chronic hepatitis B (CHB)-related cirrhosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand
-
Laiwatthanapaisan R, Sripongpun P, Chamroonkul N, Dechaphunkul A, Sathitruangsak C, Sakdejayont S, Kongkamol , Piratvisuth T
- KMID: 2467246
- Clin Mol Hepatol.
- 2019 Dec;25(4):366-373.
- doi: 10.3350/cmh.2018.0111
BACKGROUND/AIMS: Hepatitis B virus reactivation (HBVr) following chemotherapy (CMT) is well-known among hematologic malignancies, and screening recommendations are established. However, HBVr data in solid organ malignancy (SOM) patients are limited.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Statin Use on Liver Cancer Mortality Considering Hypercholesterolemia and Obesity in Patients with Non-Cirrhotic Chronic Hepatitis B
-
Kim GA, Shim JJ, Lee JS, Kim BH, Kim JW, Oh CH, Oh CM, Oh IH, Park SY
- KMID: 2463800
- Yonsei Med J.
- 2019 Dec;60(12):1203-1208.
- doi: 10.3349/ymj.2019.60.12.1203
Little is known about the benefits of statin use on liver cancer mortality among patients with chronic hepatitis B (CHB) considering hypercholesterolemia and obesity. A nationwide retrospective cohort study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between Body Mass Index and Hepatitis B antibody seropositivity in children
-
Kwon Y, Jeong SJ
- KMID: 2465644
- Korean J Pediatr.
- 2019 Nov;62(11):416-421.
- doi: 10.3345/kjp.2019.00563
BACKGROUND: The seropositivity rate of hepatitis B surface antigen (anti-HBs) antibodies is known to be ≥95% after hepatitis B virus vaccination during infancy. However, a low level or absence of... -
- CITED
-
- Close
- SHARE
-
- Close
- New Biomarkers of Chronic Hepatitis B
-
Mak LY, Seto WK, Fung J, Yuen MF
- KMID: 2464306
- Gut Liver.
- 2019 Nov;13(6):589-595.
- doi: 10.5009/gnl18425
Chronic hepatitis B (CHB) infection leads to clinically heterogeneous disease outcomes. Different viral markers are utilized to monitor treatment effects and predict risk of complications in patients with CHB. Hepatitis... -
- CITED
-
- Close
- SHARE
-
- Close
- New Potential Therapies for Chronic Hepatitis B
-
Yoo SH, Kwon JH
- KMID: 2464185
- Korean J Gastroenterol.
- 2019 Nov;74(5):267-273.
- doi: 10.4166/kjg.2019.74.5.267
A HBV infection is a dynamic disease and long-term liver inflammation contributes to the development of liver cirrhosis and hepatocellular carcinoma. Currently available nucleos(t)ide analogues and pegylated interferon are effective... -
- CITED
-
- Close
- SHARE
-
- Close
- Prophylactic Antiviral Treatment in Immunosuppressed Chronic Hepatitis B Patients
-
Yoon EL
- KMID: 2464184
- Korean J Gastroenterol.
- 2019 Nov;74(5):258-266.
- doi: 10.4166/kjg.2019.74.5.258
Improved management of chronic hepatitis B patients with oral nucleos(t)ide analogues has increased the number of these patients who are getting older and have other accompanying comorbidities. These comorbidities frequently... -
- CITED
-
- Close
- SHARE
-
- Close
- Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
-
Lee HW
- KMID: 2464183
- Korean J Gastroenterol.
- 2019 Nov;74(5):251-257.
- doi: 10.4166/kjg.2019.74.5.251
Multiple studies have shown that oral antiviral therapies reduced the incidence of hepatocellular carcinoma (HCC) and improved the survival of patients with chronic hepatitis B when compared with that of... -
- CITED
-
- Close
- SHARE
-
- Close
- Natural History and Treatment Indications of Chronic Hepatitis B
-
Sinn DH
- KMID: 2464182
- Korean J Gastroenterol.
- 2019 Nov;74(5):245-250.
- doi: 10.4166/kjg.2019.74.5.245
HBV is the most common etiology of both liver cirrhosis and hepatocellular carcinoma in Korea. Despite much progress made, the currently available antiviral therapies cannot eradicate or eliminate this virus.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes of patients with a single hepatocellular carcinoma less than 5 cm treated with transarterial chemoembolization
-
Baek MY, Yoo JJ, Jeong SW, Jang JY, Kim YK, Jeong SO, Lee SH, Kim SG, Cha SW, Kim YS, Cho YD, Kim HS, Kim BS, Kim YJ, Park SY
- KMID: 2463480
- Korean J Intern Med.
- 2019 Nov;34(6):1223-1232.
- doi: 10.3904/kjim.2018.058
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) is performed for single hepatocellular carcinoma (HCC) that are not eligible for surgery or ablation therapy. We investigated the clinical outcomes of patients with a single... -
- CITED
-
- Close
- SHARE
-
- Close
- A case report of bleeding from duodenal varices treated with percutaneous transhepatic obliteration
-
Lee JH, Kim TH, Choi JW, Kim SY, Choi JY, Lee CK, Park BK, Chung JB
- KMID: 2464711
- Int J Gastrointest Interv.
- 2019 Oct;8(4):174-177.
- doi: 10.18528/ijgii190002
Duodenal varices are ectopic in nature and account for 40% of all ectopic bleeding cases. Ectopic variceal bleeding is rare (1%–5% of all variceal bleeding cases). The three principle approaches... -
- CITED
-
- Close
- SHARE
-
- Close
- Patchy echogenicity of the liver in patients with chronic hepatitis B does not indicate poorer elasticity
-
Wu S, Tu R, Liang X
- KMID: 2464512
- Ultrasonography.
- 2019 Oct;38(4):327-335.
- doi: 10.14366/usg.18071
PURPOSE: This study was conducted to investigate whether the presence of patchy echogenicity in the liver of patients with chronic hepatitis B (CHB) is predictive of liver stiffness. METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
- Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
-
Hwang S, Song GW, Chung YK, Ahn CS, Kim KH, Moon DB, Ha TY, Jung DH, Park GC, Yoon YI, Cho HD, Kwon JH, Kang SH, Jeong IJ, Choi JU, Lee SG
- KMID: 2459094
- J Korean Med Sci.
- 2019 Oct;34(38):e251.
- doi: 10.3346/jkms.2019.34.e251
BACKGROUND: Prophylaxis for hepatitis B virus (HBV) recurrence is essential after liver transplantation (LT) in HBV-associated recipients. This study established an individualized HBV prophylaxis protocol, through optimization of hepatitis B... -
- CITED
-
- Close
- SHARE
-
- Close
